Join to View Full Profile
Fulcrum TherapeuticsCambridge, MA 02139
Dr. Fraser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Infectious Diseases, 1997 - 2000- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1994 - 1997
University of Cape Town Faculty of MedicineClass of 1987
Certifications & Licensure
MA State Medical License 2000 - 2025
Publications & Presentations
PubMed
- 19 citationsArachidonic acid inhibition of the NLRP3 inflammasome is a mechanism to explain the anti-inflammatory effects of fasting.Milton Pereira, Jonathan Liang, Joy Edwards-Hicks, Allison M Meadows, Christine Hinz
Cell Reports. 2024-02-27 - 39 citationsPosoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting.Thomas Pfeiffer, Ifigeneia Tzannou, Mengfen Wu, Carlos Ramos, Ghadir Sasa
Clinical Cancer Research. 2023-01-17 - 4 citationsEvaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorva...Luzelena Caro, Thomayant Prueksaritanont, Christine Fandozzi, Hwa-Ping Feng, Zifang Guo
Clinical Drug Investigation. 2021-02-01
Press Mentions
- Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Q4 2022 Earnings Call TranscriptMarch 13th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
